Literature DB >> 29532638

Differential diagnosis of cholangiocarcinoma and IgG4-related sclerosing cholangitis by fluorescence in situ hybridization using transpapillary forceps biopsy specimens.

Akihisa Kato1, Itaru Naitoh1, Katsuyuki Miyabe1, Kazuki Hayashi1, Hiromu Kondo1, Michihiro Yoshida1, Hiroyuki Kato2, Toshiya Kuno2, Satoru Takahashi2, Takashi Joh1.   

Abstract

BACKGROUND: Fluorescence in situ hybridization (FISH) of cytology specimens has been used to diagnose biliary strictures. However, the usefulness of FISH for differentiating between cholangiocarcinoma (CCA) and IgG4-related sclerosing cholangitis (IgG4-SC) has not been evaluated in forceps biopsy specimens.
METHODS: We retrospectively reviewed 74 specimens obtained by transpapillary forceps biopsy between 2008 and 2015 from 49 consecutive patients with CCA and 25 with IgG4-SC. Specimens were considered positive for malignancy by FISH with UroVysion® if at least five cells exhibited polysomy (a gain of two or more in chromosomes 3, 7, or 17).
RESULTS: A total of 27 (55.1%) patients with CCA, but none of the patients with IgG4-SC, were positive for malignancy by FISH. The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of FISH for the diagnosis of CCA were 55.1%, 100%, 100%, 53.2%, and 70.3%, respectively. The complementary use of FISH increased the sensitivity of hematoxylin-and-eosin (H&E) staining from 69.4% to 77.6%; the specificity was not reduced when either H&E or FISH was positive.
CONCLUSIONS: The use of FISH in the analysis of forceps biopsy specimens might be one option to differentiate CCA from IgG4-SC.
© 2018 Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Entities:  

Keywords:  Cholangiocarcinoma; Fluorescence in situ hybridization; IgG4-related sclerosing cholangitis; Transpapillary forceps biopsy

Mesh:

Substances:

Year:  2018        PMID: 29532638     DOI: 10.1002/jhbp.536

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Sci        ISSN: 1868-6974            Impact factor:   7.027


  5 in total

Review 1.  Endoscopic retrograde cholangiopancreatography and intraductal ultrasonography in the diagnosis of autoimmune pancreatitis and IgG4-related sclerosing cholangitis.

Authors:  Itaru Naitoh; Takahiro Nakazawa
Journal:  J Med Ultrason (2001)       Date:  2021-07-31       Impact factor: 1.314

2.  An Increased Chromosome 7 Copy Number in Endoscopic Bile Duct Biopsy Specimens Is Predictive of a Poor Prognosis in Cholangiocarcinoma.

Authors:  Akihisa Kato; Itaru Naitoh; Katsuyuki Miyabe; Kazuki Hayashi; Michihiro Yoshida; Yasuki Hori; Makoto Natsume; Naruomi Jinno; Go Asano; Hiroyuki Kato; Toshiya Kuno; Satoru Takahashi; Hiromi Kataoka
Journal:  Dig Dis Sci       Date:  2018-09-12       Impact factor: 3.199

Review 3.  Brush Cytology, Forceps Biopsy, or Endoscopic Ultrasound-Guided Sampling for Diagnosis of Bile Duct Cancer: A Meta-Analysis.

Authors:  Seung Bae Yoon; Sung-Hoon Moon; Sung Woo Ko; Hyun Lim; Ho Suk Kang; Jong Hyeok Kim
Journal:  Dig Dis Sci       Date:  2021-07-14       Impact factor: 3.487

4.  Use of Endoscopic Scraper and Cell Block Technique as a Replacement for Conventional Brush for Diagnosing Malignant Biliary Strictures.

Authors:  Akihisa Kato; Hiroyuki Kato; Itaru Naitoh; Kazuki Hayashi; Michihiro Yoshida; Yasuki Hori; Kenta Kachi; Go Asano; Hidenori Sahashi; Tadashi Toyohara; Kayoko Kuno; Yusuke Kito; Satoru Takahashi; Hiromi Kataoka
Journal:  Cancers (Basel)       Date:  2022-08-27       Impact factor: 6.575

5.  Refined pancreatobiliary UroVysion criteria and an approach for further optimization.

Authors:  Daniel Mettman; Azhar Saeed; Janna Shold; Raquele Laury; Andrew Ly; Irfan Khan; Shivani Golem; Mojtaba Olyaee; Maura O'Neil
Journal:  Cancer Med       Date:  2021-08-10       Impact factor: 4.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.